Vanderbilt Institute for Clinical and Translational Research (VICTR)

Event showcases REDCap’s data management versatility

Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.

New lab formulary improves quality, cuts cost

An effort at Vanderbilt University Medical Center (VUMC) to enhance clinical decision making through cross-departmental collaboration and effective use of diagnostics has improved patient care and saved the institution more than $1 million in 2016, VUMC officials reported this week.

Translational Research Forum set for Oct. 13

Jacob Corn, Ph.D., a pioneer in next-generation genome editing at the University of California Berkeley, will be the guest speaker at the 2017 Vanderbilt Translational Research Forum Oct. 13 at the Student Life Center.

Community key to gender identity research effort

One of the key elements of the Vanderbilt Program for LGBTI Health, an innovative effort to improve health care for lesbian, gay, bisexual, transgender and intersex patients, is community engagement.

elderly Asian mother and adult daughter

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

Lindsell named to key VICTR, IMPH and Biostatistics leadership roles

Christopher Lindsell, Ph.D., nationally known for building clinical, translational and emergency medicine research programs at the University of Cincinnati, has been named director of the Research Methods Program in the Vanderbilt Institute of Clinical and Translational Research (VICTR).

1 3 4 5 6 7